Cannabidiol inhibits angiogenesis by multiple mechanisms.

Solinas, M; Massi, P; Cantelmo, A R; Cattaneo, M G; Cammarota, R; Bartolini, D; Cinquina, V; Valenti, M; Vicentini, L M; Noonan, D M; Albini, A; Parolaro, D

Solinas, M; Massi, P; Cantelmo, A R; Cattaneo, M G; Cammarota, R; Bartolini, D; Cinquina, V; Valenti, M; Vicentini, L M; Noonan, D M; Albini, A; Parolaro, D.

Affiliation

Solinas M; Department of Biomedical, Computer and Communication Sciences, University of Insubria, Busto Arsizio (VA), Italy.

Br J Pharmacol ; 167(6): 1218-31, 2012 Nov.

Article in En | MEDLINE | ID: mdl-22624859

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Cannabidiol/therapeutic use; Neovascularization, Pathologic/drug therapy; Angiogenesis Inhibitors/pharmacology; Animals; Cannabidiol/pharmacology; Cell Movement/drug effects; Heparin; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic/chemically induced; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabidiol / Angiogenesis Inhibitors / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Br J Pharmacol Year: 2012 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google